Literature DB >> 18031330

Glanders: off to the races with Burkholderia mallei.

Gregory C Whitlock1, D Mark Estes, Alfredo G Torres.   

Abstract

Burkholderia mallei, the etiologic agent of the disease known as glanders, is primarily a disease affecting horses and is transmitted to humans by direct contact with infected animals. The use of B. mallei as a biological weapon has been reported and currently, there is no vaccine available for either humans or animals. Despite the history and highly infective nature of B. mallei, as well as its potential use as a bio-weapon, B. mallei research to understand the pathogenesis and the host responses to infection remains limited. Therefore, this minireview will focus on current efforts to elucidate B. mallei virulence, the associated host immune responses elicited during infection and discuss the feasibility of vaccine development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18031330     DOI: 10.1111/j.1574-6968.2007.00949.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  81 in total

Review 1.  A decade of Burkholderia cenocepacia virulence determinant research.

Authors:  Slade A Loutet; Miguel A Valvano
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

2.  Genetic tools for allelic replacement in Burkholderia species.

Authors:  Ashley R Barrett; Yun Kang; Ken S Inamasu; Mike S Son; Joseph M Vukovich; Tung T Hoang
Journal:  Appl Environ Microbiol       Date:  2008-05-23       Impact factor: 4.792

3.  VgrG-5 is a Burkholderia type VI secretion system-exported protein required for multinucleated giant cell formation and virulence.

Authors:  Sandra Schwarz; Pragya Singh; Johanna D Robertson; Michele LeRoux; Shawn J Skerrett; David R Goodlett; T Eoin West; Joseph D Mougous
Journal:  Infect Immun       Date:  2014-01-22       Impact factor: 3.441

4.  Discovery of scmR as a global regulator of secondary metabolism and virulence in Burkholderia thailandensis E264.

Authors:  Dainan Mao; Leah B Bushin; Kyuho Moon; Yihan Wu; Mohammad R Seyedsayamdost
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-20       Impact factor: 11.205

Review 5.  Regulation of Virulence by Two-Component Systems in Pathogenic Burkholderia.

Authors:  Matthew M Schaefers
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

6.  Virulence of Burkholderia mallei quorum-sensing mutants.

Authors:  Charlotte Majerczyk; Loren Kinman; Tony Han; Richard Bunt; E Peter Greenberg
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

Review 7.  Antibiotic resistance in Burkholderia species.

Authors:  Katherine A Rhodes; Herbert P Schweizer
Journal:  Drug Resist Updat       Date:  2016-07-30       Impact factor: 18.500

8.  Pathema: a clade-specific bioinformatics resource center for pathogen research.

Authors:  Lauren M Brinkac; Tanja Davidsen; Erin Beck; Anuradha Ganapathy; Elisabet Caler; Robert J Dodson; A Scott Durkin; Derek M Harkins; Hernan Lorenzi; Ramana Madupu; Yinong Sebastian; Susmita Shrivastava; Mathangi Thiagarajan; Joshua Orvis; Jaideep P Sundaram; Jonathon Crabtree; Kevin Galens; Yongmei Zhao; Jason M Inman; Robert Montgomery; Seth Schobel; Kevin Galinsky; David M Tanenbaum; Adam Resnick; Nikhat Zafar; Owen White; Granger Sutton
Journal:  Nucleic Acids Res       Date:  2009-10-20       Impact factor: 16.971

9.  The early stage of bacterial genome-reductive evolution in the host.

Authors:  Han Song; Junghyun Hwang; Hyojeong Yi; Ricky L Ulrich; Yan Yu; William C Nierman; Heenam Stanley Kim
Journal:  PLoS Pathog       Date:  2010-05-27       Impact factor: 6.823

10.  Comparison of the in vitro and in vivo susceptibilities of Burkholderia mallei to Ceftazidime and Levofloxacin.

Authors:  Barbara M Judy; Gregory C Whitlock; Alfredo G Torres; D Mark Estes
Journal:  BMC Microbiol       Date:  2009-05-09       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.